ABOUT US
Investors

Profectus BioSciences has raised more than $69 million in funding, including $20 million in private equity financing and more than $49 million in grants and contracts from the National Institutes of Health, the Malaria Vaccine Initiative, and other non-governmental organizations.

Cross Atlantic Capital Partners

CONTACT  |  SITEMAP
© 2016 Profectus BioSciences, Inc. All Rights Reserved.  |  User Login